In this study, we showed that PTX-3 levels, in both FMF attack and attack-free periods, were significantly higher than in the control group. Finally, PTX-3 may be a promising biomarker for FMF diagnosis and may predict FMF attacks (Tab. 2, Fig. 2, Ref. 18).
Objective: The aim of this study was to evaluate the upper extremity functions of individuals with type 2 diabetes mellitus and to compare them with those of healthy subjects. Methods:The study included 36 diabetic patients (mean age: 55.05±5.85 years; 21 female, 15 male) and 36 healthy control subjects (mean age: 53.52±7.74 years; 20 female, 16 male). Grip strength was evaluated using a hand dynamometer. Upper extremity endurance was evaluated using the Unsupported Upper Limb Exercise Test (UULEX), and upper extremity disability level with the Disabilities of the Arm Shoulder and Hand Test (DASH-T). Results:The diabetic patients obtained lower scores of upper extremity endurance (p<0.05) and the disability level of the diabetics was found to be higher than that of the healthy control group (p<0.05). No significant difference was determined between the groups in terms of grip strength (p>0.05). Conclusion:In individuals with type 2 diabetes mellitus, there is a significant decrease in upper extremity endurance and an increase in the level of upper extremity disability.
Aim: During rapid sequence intubation (RSI), the O 2 reserve limits the intubation duration. The study objective was to examine the impact of RSI on arterial blood gases (ABG) during the preoxygenation phase.Methods: This open, prospective clinical study examined samples of patients who had endotracheal intubation (ETI) as RSI between March 2014 and September 2014 in our emergency department. The variations in ABG PaO 2 and PaCO 2 before and after preoxygenation and after intubation were examined and compared with demographic and clinical variables.Results: The study included 67 patients (46 male, 21 female) with a mean age of 69.9 years. SBP, DBP, and MABP decreased, while pulse rate and SpO 2 increased. No difference was observed between PaO 2 values and demographic and clinical variables; however, a statistically significant relationship was found between the difference (Δ) between PaO 2 values measured after endotracheal tracheal intubation (ETI) and after preoxygenation and the ABG SpO 2 and the SpO 2 classification before preoxygenation. Conclusion:The relationship between SpO 2 and its classification following ETI and increased ABG SpO 2 was statistically significant. Our real-life study emphasises that deciding on intubation without desaturating patients could have positive effects on intubation success. Regardless, increasing SpO 2 prior to ETI will contribute positively to the O 2 reserve by the end of ETI.The ΔPaO 2 , before and after preoxygenation, was not affected by age; gender; body mass index (BMI) and its classification; GCSS; vital signs and ABG find-ings gathered before preoxygenation; respiration rate (RR) during preoxygenation; preoxygenation duration; oral air passage usage or air leakage.
M esenteric vein thrombosis (MVT) is a rare cause of acute abdomen. It is evaluated as a primary MVT whose etiology cannot be determined and secondary MVT caused by a predisposing factor. Predisposing factors include infection which leads to hypercoagulability; abdominal surgery; deficiency of protein C, protein S, and antithrombin III; factor V Leiden mutation; presence of lupus anticoagulant; antiphospholipid syndrome; and malignancy. The disease commences with non-specific progressive abdominal pain and it might worsen with advancement of ischemia along with nausea, vomiting, and bloody diarrhea and finally, it might lead to sepsis. MVT has high mortality rates if left untreated. This study discusses a case in which the patient presented to the emergency department with complaints of abdominal pain and fever, computed tomography (CT) revealed thrombosis in the ileocolic branch of the superior mesenteric vein, and the complaints completely improved after LMWH treatment. Case ReportAn 80-year-old man presented to the emergency department complaining of progressive, worsening abdominal pain for 3 days and fever, which began on that morning. His vital signs were as follows: blood pressure, 110/65 mm Hg; heart rate, 110/min; and body temperature, 38.8°C. His physical examination revealed tenderness in right lower quadrant of the abdomen with palpation and no guarding or rebound tenderness. According to laboratory studies, his WBC was 13700/mm 3 ; CRP levels were 17 mg/dl; and kidney function, liver enzymes tests, and blood electrolytes were evaluated to be normal. There was no significant finding on erect AXR and abdominal ultrasonography. Therefore, contrast-enhanced abdominal CT was required, and a thrombus in the ileocolic branch of the superior mesenteric vein and inflammation in the surrounding fatty mesenteric tissue were observed (Fig. 1). There were no supSuperior mesenteric vein thrombosis is a rare cause of acute abdomen. Patients usually complain of non-specific abdominal pain, which may show progress with secondary complaints, such as nausea, vomiting, and hematochezia. Mesenteric vein thrombosis has a mortality rate of 15% to 40%; early diagnosis plays an important role in treatment. An 80-year-old male patient presented at the Near East Universiry emergency department with complaints of fever and abdominal pain, underwent contrast-enhanced abdominal computed tomography, and was diagnosed with thrombosis in the ileocolic branch of the superior mesenteric vein. The complaints were treated with low molecular weight heparine (LMWH), and surgical intervention was not necessary.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.